Literature DB >> 23968931

Persistence with cholinesterase inhibitor treatment in Alzheimer's disease.

Fadi Massoud1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23968931     DOI： 10.1017/s0317167100014815

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN： 0317-1671            Impact factor:   2.104


× No keyword cloud information.
  2 in total

Review 1.  Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factors.

Authors:  Colleen J Maxwell; Kathryn Stock; Dallas Seitz; Nathan Herrmann
Journal:  Can J Psychiatry       Date:  2014-12       Impact factor: 4.356

2.  Persistence and adherence to rivastigmine in patients with dementia: Results from a noninterventional, retrospective study using the National Health Insurance research database of Taiwan.

Authors:  Chee-Jen Chang; Tse-Chih Chou; Chiung-Chih Chang; Ta-Fu Chen; Chaur-Jong Hu; Jong-Ling Fuh; Wenfu Wang; Chiung-Mei Chen; Winco Hsu; Chin-Chang Huang
Journal:  Alzheimers Dement (N Y)       Date:  2018-07-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.